Who Owns Novo Nordisk A/S Stock?
NYSE: NVOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 38.18 +0.07%
Ownership breakdown
- Held by institutions
- 9.89%
- Held by insiders
- 0.00%
- Institutional holders
- 1,603
- Institutions 9.9%
- Insiders 0.0%
- Public and other 90.1%
Who owns Novo Nordisk A/S stock?
Institutional investors own about 9.9% of Novo Nordisk A/S's shares, spread across 1,603 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 0.00% of NVO.
The largest institutional holders are Dodge & Cox Inc. (0.60%), LOOMIS SAYLES & CO L P (0.55%) and Franklin Resources, Inc. (0.38%). Together, the top 10 institutions control 3.6% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their NVO positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of NVO
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Dodge & Cox Inc. | 20.40M | 0.60% | +5.5% |
| LOOMIS SAYLES & CO L P | 18.59M | 0.55% | +9.3% |
| Franklin Resources, Inc. | 13.04M | 0.38% | -18.9% |
| Price (T.Rowe) Associates Inc | 11.70M | 0.35% | +5.8% |
| Morgan Stanley | 11.66M | 0.34% | +7.3% |
| Bank of America Corporation | 11.18M | 0.33% | +3.8% |
| Capital International Investors | 9.72M | 0.29% | -17.6% |
| Folketrygdfondet | 9.52M | 0.28% | +4.9% |
| Goldman Sachs Group Inc | 9.18M | 0.27% | +79.3% |
| Fisher Asset Management, LLC | 8.32M | 0.25% | -7.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of NVO
| Fund | Shares | % Held |
|---|---|---|
| Dodge & Cox Funds-Dodge & Cox Stock Fund | 15.24M | 0.45% |
| PUTNAM LARGE CAP VALUE FUND | 7.98M | 0.24% |
| WASHINGTON MUTUAL INVESTORS FUND | 5.34M | 0.16% |
| LOOMIS SAYLES FUNDS II-Loomis Sayles Growth Fund | 5.11M | 0.15% |
| AMERICAN BALANCED FUND | 4.75M | 0.14% |
| TR PRICE-Price (T.Rowe) International Growth Equity Trust | 3.45M | 0.10% |
| T. ROWE PRICE Intl Fd.S, INC.-T. Rowe Price Intl Stock Fd. | 2.64M | 0.08% |
| Putnam ETF Trust-Putnam Focused Large Cap Value ETF | 2.04M | 0.06% |
| ALGER INSTITUTIONAL FUNDS-Alger Focus Equity Fund | 1.77M | 0.05% |
| T. ROWE PRICE Eqy. INCOME Fd., INC.-T. Rowe Price Eqy. Income Fd. | 1.75M | 0.05% |
Frequently asked questions
Who is the largest shareholder of Novo Nordisk A/S?
Dodge & Cox Inc. is the largest institutional shareholder of NVO, owning 0.60% of shares outstanding (20.40M shares) as of its latest 13F filing.
What percentage of Novo Nordisk A/S is owned by institutions?
Institutions own about 9.9% of NVO shares and 9.9% of the public float.
How much of Novo Nordisk A/S do insiders own?
Insiders, such as officers and directors, own about 0.00% of NVO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.